The TSH response to domperidone reflects the biological activity of prolactin in macroprolactinaemia and hyperprolactinaemia

Clinical Endocrinology

Volumn 59, Issue 5, 2003, Pages 580-584

  Pinto, L P ^a   Hanna, F W F ^b   Evans, L M ^a   Davies, J S ^a   John, R ^a   Scanlon, M F ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b PRINCE CHARLES HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOMPERIDONE; DOPAMINE RECEPTOR STIMULATING AGENT; PROLACTIN; THYROTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; HYPERPROLACTINEMIA; IMMUNOASSAY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROLACTIN RELEASE; PROLACTINOMA; SIDE EFFECT; THYROTROPIN RELEASE;

ADULT; DOMPERIDONE; DOPAMINE ANTAGONISTS; FEMALE; HUMANS; HYPERPROLACTINEMIA; MIDDLE AGED; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA; STATISTICS, NONPARAMETRIC; THYROTROPIN;

EID: 0242288584     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01887.x     Document Type: Article

References (15)

1. Bjoro, T., Morkrid, L., Worgeland, R., Turter, A., Kvistborg, A., Sand, T. & Torgesen, P. (1995) Frequency of hyperprolactinaemia due to large molecular weight prolactin (150-170 kD PRL). Scandinavian Journal of Clinical and Laboratory Investigations, 55, 139-147.
2. Cattaneo, F.A. & Fahie-Wilson, M.N. (2001) Concomitant occurrence of macroprolactin, exercise-induced amenorrhoea, and a pituitary lesion: a diagnostic pitfall. Journal of Neurosurgery, 95, 334-337.
3. Davis, M.J. & Howlett, T.A. (1996) A survey of the current methods used in the UK to assess pituitary function. Journal of the Royal Society of Medicine, 89, 159-164.
4. Fahie-Wilson, M.N. & Soule, S.G. (1997) Macroprolactinaemia: contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol. Annals of Clinical Biochemistry, 34, 252-258.
5. Hattori, N. (1996) The frequency of macroprolactinaemia in pregnant women and the heterogeneity of etiologies. Journal of Clinical Endocrinology and Metabolism, 81, 586-590.
6. Hattori, R., Ikekubo, K., Ishihara, T., Mondera, K., Hino, M. & Kurahachi, H. (1994) Correlation of the antibody titres with serum prolactin levels and their clinical course in patients with anti-prolactin auto antibody. European Journal of Endocrinology, 130, 438-445.
7. John, R., McDowell, I.F.W., Scanlon, M.F. & Ellis, A.R. (2000) Macroprolactin reactivities in prolactin assays: an issue for clinical laboratories and equipment manufacturers. Clinical Chemistry, 46, 884-885.
8. Jordan, R.M. & Kendall, J.W. (1978) Dissociation of plasma and CSF prolactin heterogeneity. Acta Endocrinologica, 89, 38-47.
9. Leite, V., Cosby, H., Sobrinho, L.G., Fresnoza, A., Santos, A.M. & Friesen, H.G. (1992) Characterisation of big, big prolactin in patients with hyperprolactinaemia. Clinical Endocrinology, 37, 365-372.
10. Massara, F., Camanni, F., Martra, M., Dolfin, G.C., Muller, E.E. & Molinatti, G.M. (1983) Reciprocal pattern of the TSH and PRL responses to dopamine receptor blockade in women with physiological or pathological hyperprolactinaemia. Clinical Endocrinology, 18, 103-110.
11. Miyai, K., Ichihara, K., Kondo, K. & Mori, S. (1986) Asymptomatic hyperprolactinaemia and prolactinoma in the general population - mass screening by paired assays of serum PRL. Clinical Endocrinology, 25, 549-554.
12. Scanlon, M.F., Peters, J.R., Salvador, J., Richards, S.H., John, R., Howell, S., Williams, E.D., Thomas, J.P. & Hall, R. (1986) The preoperative and postoperative investigation of TSH and prolactin release in the management of patients with hyperprolactinaemia due to prolactinomas and non-functional pituitary tumours: relationship to adenoma size at surgery. Clinical Endocrinology, 24, 435-446.
13. Scanlon, M.F., Rodriguez-Amao, M.D., McGregor, A.M., Weightman, D., Lewis, M., Cook, D.B., Gomez-Pan, A. & Hall, R. (1981) Altered dopaminergic regulation of thyrotropin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function. Clinical Endocrinology, 14, 133-143.
14. Smith, C.R. & Norman, M.R. (1990) Prolactin and growth hormone: molecular heterogeneity and measurement in serum. Annals of Clinical Biochemistry, 27, 542-550.
15. Webster, J., Page, M.D., Bevan, J.S., Richards, S.H., Douglas-John, A.G. & Scanlon, M.F. (1992) Low recurrence rate after partial hypophysectomy for prolactinoma; the predictive value of dynamic prolactin function tests. Clinical Endocrinology, 36, 35-44.